Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Zeng-Fu Shang, Lan Yu, Bing Li, Wen-Zhi Tu, Yu Wang, Xiao-Dan Liu, Hua Guan, Bo Huang, Wei-Qing Rang & Ping-Kun Zhou. (2012) 4E-BP1 participates in maintaining spindle integrity and genomic stability via interacting with PLK1. Cell Cycle 11:18, pages 3463-3471.
Read now
Read now
Articles from other publishers (30)
Sandy Che-Eun S. Lee, Andrea Hye An Pyo & Marianne Koritzinsky. (2023) Longitudinal dynamics of the tumor hypoxia response: From enzyme activity to biological phenotype. Science Advances 9:47.
Crossref
Crossref
Ioannis D. Dimitriou, David Meiri, Yulia Jitkova, Alisha R. Elford, Marianne Koritzinsky, Aaron D. Schimmer, Pamela S. Ohashi, Nahum Sonenberg & Robert Rottapel. (2022) Translational Control by 4E-BP1/2 Suppressor Proteins Regulates Mitochondrial Biosynthesis and Function during CD8+ T Cell Proliferation. The Journal of Immunology 208:12, pages 2702-2712.
Crossref
Crossref
Guangzhu Dong, Rui Zhang, Qi Hu, Elizabeth M. Martin, Yufeng Qin, Chuncheng Lu, Yankai Xia, Xinru Wang & Guizhen Du. (2022) Prothioconazole induces cell cycle arrest by up-regulation of EIF4EBP1 in extravillous trophoblast cells. Archives of Toxicology 96:2, pages 559-570.
Crossref
Crossref
Shree Padma Metur & Daniel J. Klionsky. (2021) Adaptive immunity at the crossroads of autophagy and metabolism. Cellular & Molecular Immunology 18:5, pages 1096-1105.
Crossref
Crossref
Zaka Abbaszade, Bakiye Goker Bagca & Cigir Biray Avci. (2021) Molecular biological investigation of temozolomide and KC7F2 combination in U87MG glioma cell line. Gene 776, pages 145445.
Crossref
Crossref
Alia Ghoneum & Neveen Said. (2019) PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics. Cancers 11:7, pages 949.
Crossref
Crossref
Russell G. Jones & Edward J. Pearce. (2017) MenTORing Immunity: mTOR Signaling in the Development and Function of Tissue-Resident Immune Cells. Immunity 46:5, pages 730-742.
Crossref
Crossref
Yufeng Miao, Lige Chen, Cuifen Shi, Rengen Fan, Ping Chen, Hongqi Liu, Aihua Xia & Haixin Qian. (2017) Increased phosphorylation of 4E‑binding protein 1 predicts poor prognosis for patients with colorectal cancer. Molecular Medicine Reports.
Crossref
Crossref
Mª Carmen Herrero-Sánchez, Concepción Rodríguez-Serrano, Julia Almeida, Laura San Segundo, Susana Inogés, Ángel Santos-Briz, Jesús García-Briñón, Luis Antonio Corchete, Jesús F. San Miguel, Consuelo del Cañizo & Belén Blanco. (2016) Targeting of PI3K/AKT/mTOR pathway to inhibit T cell activation and prevent graft-versus-host disease development. Journal of Hematology & Oncology 9:1.
Crossref
Crossref
Laetitia Mazelin, Baptiste Panthu, Anne-Sophie Nicot, Edwige Belotti, Lionel Tintignac, Geoffrey Teixeira, Qing Zhang, Valérie Risson, Dominique Baas, Emilie Delaune, Geneviève Derumeaux, Daniel Taillandier, Théophile Ohlmann, Michel Ovize, Yann-Gaël Gangloff & Laurent Schaeffer. (2016) mTOR inactivation in myocardium from infant mice rapidly leads to dilated cardiomyopathy due to translation defects and p53/JNK-mediated apoptosis. Journal of Molecular and Cellular Cardiology 97, pages 213-225.
Crossref
Crossref
Ma Carmen Herrero-Sánchez, Concepción Rodríguez-Serrano, Julia Almeida, Laura San-Segundo, Susana Inogés, Ángel Santos-Briz, Jesús García-Briñón, Jesús F. SanMiguel, Consuelo Del Cañizo & Belén Blanco. (2016)
Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-
versus
-host disease control
. British Journal of Haematology 173:5, pages 754-768.
Crossref
Crossref
Chao Zhang, Lei Yang, Ya-di Geng, Fa-liang An, Yuan-zheng Xia, Chao Guo, Jian-guang Luo, Lu-yong Zhang, Qing-long Guo & Ling-yi Kong. (2016) Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cells. Oncotarget 7:19, pages 27819-27837.
Crossref
Crossref
Lan Yu, Zeng-Fu Shang, Jian Wang, Hongtao Wang, Fang Huang, Zhe Zhang, Ying Wang, Jianguang Zhou & Shanhu Li. (2015) PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability. Oncotarget 6:24, pages 20356-20369.
Crossref
Crossref
Michael J. Clemens, Androulla Elia & Simon J. Morley. 2015. Systems Biology of Cancer. Systems Biology of Cancer
70
92
.
. 2015. Systems Biology of Cancer. Systems Biology of Cancer
35
92
.
Zheng Fang, Lei Lu, Zhiqiang Tian & Kunlun Luo. (2014) Overexpression of phosphorylated 4E-binding protein 1 predicts lymph node metastasis and poor prognosis of Chinese patients with hilar cholangiocarcinoma. Medical Oncology 31:5.
Crossref
Crossref
Armen Parsyan, James L. Chen, Raphael Pollock & Sarkis Meterissian. 2014. Translation and Its Regulation in Cancer Biology and Medicine. Translation and Its Regulation in Cancer Biology and Medicine
453
466
.
P. Stafford, J. Higham, A. Pinnock, C. Murdoch, C.W.I. Douglas, G.P. Stafford & D.W. Lambert. (2013)
Gingipain-dependent degradation of mammalian target of rapamycin pathway proteins by the periodontal pathogen
Porphyromonas gingivalis
during invasion
. Molecular Oral Microbiology 28:5, pages 366-378.
Crossref
Crossref
Michael J. Clemens, Androulla Elia & Simon J. Morley. (2013) Requirement for the eIF4E Binding Proteins for the Synergistic Down-Regulation of Protein Synthesis by Hypertonic Conditions and mTOR Inhibition. PLoS ONE 8:8, pages e71138.
Crossref
Crossref
Latika Kohli, Niroop Kaza, Tatjana Coric, Stephanie J. Byer, Nicole M. Brossier, Barbara J. Klocke, Mary-Ann Bjornsti, Steven L. Carroll & Kevin A. Roth. (2013) 4-Hydroxytamoxifen Induces Autophagic Death through K-Ras Degradation. Cancer Research 73:14, pages 4395-4405.
Crossref
Crossref
GuoGuang Zhao, Fei Jiao, Qi Liao, HaiTao Luo, Hui Li, Liang Sun, DeChao Bu, KunTao Yu, Yi Zhao & RunSheng Chen. (2013) Genome-wide identification of cancer-related polyadenylated and non-polyadenylated RNAs in human breast and lung cell lines. Science China Life Sciences 56:6, pages 503-512.
Crossref
Crossref
Silke Reinartz, Sophie Failer, Tina Schuell & Uwe Wagner. (2012) CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells. European Journal of Cancer 48:10, pages 1558-1569.
Crossref
Crossref
Yan Jia, Vitaly Polunovsky, Peter B. Bitterman & Carston R. Wagner. (2012) Cap-Dependent Translation Initiation Factor eIF4E: An Emerging Anticancer Drug Target. Medicinal Research Reviews 32:4, pages 786-814.
Crossref
Crossref
Macarena Hernández-Jiménez, M. Irene Ayuso, M. Isabel Pérez-Morgado, Eva M. García-Recio, Alberto Alcázar, M. Elena Martín & Víctor M. González. (2012) eIF4F complex disruption causes protein synthesis inhibition during hypoxia in nerve growth factor (NGF)-differentiated PC12 cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1823:2, pages 430-438.
Crossref
Crossref
Sarah P. Blagden & Anne E. Willis. (2011) The biological and therapeutic relevance of mRNA translation in cancer. Nature Reviews Clinical Oncology 8:5, pages 280-291.
Crossref
Crossref
Eun-Chang Lee, Young-Seok Lee, Na-Hee Park, Kwang-Sup So, Young-Jin Chun & Mie-Young Kim. (2011) Ceramide Induces Apoptosis and Growth Arrest of Human Glioblastoma Cells by Inhibiting Akt Signaling Pathways. Biomolecules and Therapeutics 19:1, pages 21-26.
Crossref
Crossref
J.D. Varner, J.K. Siddiqui & S. Nayak. (2011) Modelling and analysis of an ensemble of eukaryotic translation initiation models. IET Systems Biology 5:1, pages 2-14.
Crossref
Crossref
Yoko Hirabayashi & Tohru Inoue. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
Mei Yee Koh, Taly R. Spivak-Kroizman & Garth Powis. (2009) Inhibiting the Hypoxia Response for Cancer Therapy: The New Kid on the Block. Clinical Cancer Research 15:19, pages 5945-5946.
Crossref
Crossref
Yoshikazu Nakamura, Kei Endo, Hironori Adachi & Akira Ishiguro. 2009. Translational Control in Health and Disease. Translational Control in Health and Disease
369
395
.